New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 29, 2018 - TherapeuticsMD announced the FDA approval of Bijuva (estradiol/progesterone), for the treatment of moderate to severe vasomotor symptoms due to menopause in women with a uterus.
Download PDF
Return to publications
